...the virtual elimination of methaqualone from the streets is often touted as THE outstanding success story for law-enforcement in its efforts to stem the flow of drugs. A multi-agency campaign led by the DEA proved so effective that Quaalude seemed to simply disappear from the American drug scene.
…the outcome can be serious. In some cases, we’re told, untreated lesions have led to amputation.
Read More
It’s gained acceptance as a remedy for a host of mental health problems, including major disorders.
That’s in spite of the fact that the FDA has yet to approve the drug for the treatment of any psychiatric condition.
Consumers may inadvertently find themselves addicted to tianeptine and should avoid all products containing tianeptine, especially those claiming to treat opioid use disorder.
Read More
Unfortunately, adulterating fentanyl with xylazine makes naloxone substantially less effective in terms of reviving an overdose victim.
Read More
Yes, they’re effective — for a week or two. After that, most of their effectiveness has eroded. If someone is still taking them on a daily basis, it’s probably an indication of growing dependence
Read More
As many as fifty of these NPS designer drugs have been found to date. That sounds like a lot until we realize the potential for hundreds more to appear in future.
Read More
It doesn’t much matter whether the primary addiction was to a depressant or a stimulant or some combination of both – sleep difficulties often persist well into recovery.
Read More
This in spite of the fact … that these drugs can and often do interact harmfully with one another. And regular users are at elevated risk for misuse, abuse, dependence, and/or addiction.
Read More
Anybody concerned that some GHB-based prescribed meds will be diverted for illicit use?
Read More
It appears that the presence of other drugs in the fentanyl and heroin currently flooding our streets has made naloxone, the opioid antagonist that is our primary weapon against OD fatalities, far less likely to be effective.
Read More
Now this really sounds like what we heard from Purdue Pharma in the early days of the Oxycontin epidemic.
Read More